Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

melinda mcgrath

  • Home
  •  
  • melinda mcgrath



  • Most Read
  • Latest Comments
  • Stuck in line waiting for a COVID test? This company is loving the 4+ hour wait times
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Stuck in line waiting for a COVID test? This company is loving the 4+ hour wait times
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Stuck in line waiting for a COVID test? This company is loving the 4+ hour wait times
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Stuck in line waiting for a COVID test? This company is loving the 4+ hour wait times
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Stuck in line waiting for a COVID test? This company is loving the 4+ hour wait times
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Nido Education flags profit downgrade amid delays in new childcare centre openings
    Nido Education flags profit downgrade amid delays in new childcare centre openings
    • News

  • CleanSpace sees sustainable growth with pivot to industrial sectors after the pandemic boom
    CleanSpace sees sustainable growth with pivot to industrial sectors after the pandemic boom
    • News

  • Booktopia requests ASX suspension extension amid funding concerns, ACCC fine still not paid off
    Booktopia requests ASX suspension extension amid funding concerns, ACCC fine still not paid off
    • News

  • IPO Watch: The Australian Wealth Advisory Group set for ASX entrance
    IPO Watch: The Australian Wealth Advisory Group set for ASX entrance
    • News

  • Mayfield Childcare reaches settlement to recoup $1 million from former CEO
    Mayfield Childcare reaches settlement to recoup $1 million from former CEO
    • News

  • Stuck in line waiting for a COVID test? This company is loving the 4+ hour wait times
    • News

    Stuck in line waiting for a COVID test? This company is loving the 4+ hour wait times

    Perhaps the displeasure of waiting in line for hours to get a COVID test this holiday season would be slightly allayed if you were a shareholder in a pathology company doing the leg work? Investors who saw the value in pathology and ‘pro-pandemic’ stocks like Australian Clinical Labs (ASX: ACL) will be glad to read

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.